Monica Fradkin on HCPs Administering Chemotherapy
Monica Fradkin, RN, BSN, MPH, OCN, Oncology Nursing Education Coordinator, Yale School of Nursing, Smilow Cancer Hospital at Yale-New Haven, discusses the administration of chemotherapy or biotherapy outside of the oncology setting.
Monica Fradkin, RN, BSN, MPH, OCN, Oncology Nursing Education Coordinator, Yale School of Nursing, Smilow Cancer Hospital at Yale-New Haven, discusses the administration of chemotherapy or biotherapy outside of the oncology setting.
At the Smilow Cancer Hospital at Yale-New Haven, a chemotherapy pager process was created to support the need of chemotherapy or biotherapy when given outside of oncology-- whether in an ICU setting for oncology purposes or a non-oncology reason such as autoimmune disease, transplant rejection, Crohn's disease, or colitis.
This process is used by pharmacists, nurses, and physicians to request the support of an oncology nurse regarding administration, verification, and more.
Adding Cediranib to Olaparib Increases Treatment Efficacy, But Raises Toxicity Concerns, in mCRPC
July 31st 2025A regimen of cediranib and olaparib improved radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer compared with olaparib monotherapy. However, the rate of dose reductions was doubled with the combination.
